In-House Laboratory
We have been conducting research on dendritic cell therapy for over 20 years.
In-House Laboratory
We have been conducting research on dendritic cell therapy for over 20 years.
PetBioCell is Germany’s leading provider of dendritic cell therapy in the veterinary field – with many years of experience, scientific expertise, and state-of-the-art technology. We support veterinarians and pet owners with innovative treatment approaches that strengthen the immune system and promote natural healing processes. Our dedicated team develops customized solutions to sustainably improve the quality of life for dogs, cats, and horses.
Dendritic Cell Therapy
Together with your veterinarian, we develop tailored therapies that are individually adapted to your pet and its condition.
Holistic Treatment
Our team of veterinarians, immunologists, and production experts works together with you for the well-being of your patients – and, of course, their entire families. That is our goal!
Together, we bridge the gap between cell-based immunotherapy and daily veterinary practice to sustainably improve patients’ quality of life.
Research / Cleanroom Laboratory
In our specialized laboratory, we prepare cell preparations tailored to each of our patients and, wherever possible, deliver them directly to your veterinarian’s office within 24 hours.
Innovative Immunotherapy for Animals
Our dendritic cell therapy is based on many years of experience and scientific findings in human and veterinary medicine and offers complementary treatment or a gentle alternative to traditional forms of treatment.
Personalized Care and Consultation
Whether you’re a veterinary practice or a pet owner - we handle every case personally and work together to develop tailor-made solutions for dogs, cats, or horses.
Years of Experience & Excellent Quality
With our interdisciplinary team of veterinarians, immunologists, and production experts, we guarantee the highest standards in development, manufacturing, and application.
Serving Health—Today and Tomorrow
PetBioCell stands for sustainable veterinary medicine: resource-efficient, forward-looking, and committed to improving quality of life in the long term.
Unser aktuelles Forschungsprojekt
PetBioCell arbeitet gemeinsam mit der Stiftung Tierärztliche Hochschule Hannover (TiHo) an einem Forschungsprojekt zur Entwicklung neuer immunmodulatorischer Therapieansätze für Hunde. Im Mittelpunkt steht die Untersuchung der Anwendung autologer antigenpräsentierender Zellen (tDCs) als innovative Behandlungsoption.
Ziel des Projekts ist es, neue wissenschaftliche Erkenntnisse zur Immuntherapie bei Hunden zu gewinnen und damit langfristig die veterinärmedizinischen Behandlungsmöglichkeiten zu erweitern.
Das Vorhaben wird im Rahmen des Programms „Europa für Niedersachsen“ gefördert und mit Mitteln des Europäischen Sozialfonds Plus (ESF+) sowie des Europäischen Fonds für regionale Entwicklung (EFRE) unterstützt.
Haben Sie Fragen?
Schreiben Sie uns
Latest News
We have received the grant award notification under the “Central Innovation Program for SMEs (ZIM)” program, project type: R&D collaboration project. Since June 1, 2026, the Institute for Multiphase Processes at Leibniz University Hannover and PetBioCell GmbH have been collaborating on the R&D project: “Sustainable Optimization of Hypothermic Transport Conditions for Cell-Based Immunotherapy in Veterinary Medicine.” This project is supported by the Federal Ministry for Economic Affairs and Energy (BMWE) on the basis of the decision by the German Bundestag.
Dr. rer. nat. Claudia Dettmer-Richardt
Science & Innovation
Starting December 1, 2025, we will launch our joint research project with the Hannover University of Veterinary Medicine & Small Animal Clinic Foundation: “Study on the Use of Autologous Antigen-Presenting Cells (tDCs) as an Immunomodulatory Treatment Option in Dogs.”.
Dr. Dr. Dierk E. Rebeski
Geschäftsführung, Tierarzt